Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters








Database
Language
Publication year range
1.
Immunol Allergy Clin North Am ; 34(2): 407-22, 2014 May.
Article in English | MEDLINE | ID: mdl-24745683

ABSTRACT

In approximately one-third of cases, patients with mastocytosis can display various disabling general and neuropsychological symptoms. General signs may have a major impact on quality of life. Neurologic symptoms are less frequent. In a majority of cases, the pathophysiology of these symptoms is not known but could be linked to tissular mast cell infiltration, mast cell mediator release, or both. Treatments aiming at reducing mast cell number and/or stabilizating mast cells may be useful. Preliminary results suggest that treatment with kinase inhibitors may improve symptoms of depression and cognitive impairment.


Subject(s)
Anxiety/physiopathology , Brain/physiopathology , Cognition Disorders/physiopathology , Depression/physiopathology , Mastocytosis/physiopathology , Migraine Disorders/physiopathology , Adult , Anxiety/complications , Anxiety/drug therapy , Anxiety/enzymology , Brain/drug effects , Brain/enzymology , Brain/pathology , Cognition Disorders/complications , Cognition Disorders/drug therapy , Cognition Disorders/enzymology , Depression/complications , Depression/drug therapy , Depression/enzymology , Humans , Mast Cells/drug effects , Mast Cells/enzymology , Mast Cells/pathology , Mastocytosis/complications , Mastocytosis/drug therapy , Mastocytosis/enzymology , Migraine Disorders/complications , Migraine Disorders/drug therapy , Migraine Disorders/enzymology , Protein Kinase Inhibitors/therapeutic use , Proto-Oncogene Proteins c-kit/antagonists & inhibitors , Proto-Oncogene Proteins c-kit/metabolism , Psychotropic Drugs/therapeutic use , Quality of Life
SELECTION OF CITATIONS
SEARCH DETAIL